(Q46835992)

25 December 2017

title

The effects of ziprasidone on regional c-Fos expression in the rat forebrain (English)

1 reference

25 December 2017

author name string

C A Jennings

1

1 reference

25 December 2017

J E Cluderay

2

1 reference

25 December 2017

J Gartlon

3

1 reference

25 December 2017

J Cilia

4

1 reference

25 December 2017

A Lloyd

5

1 reference

25 December 2017

D N C Jones

6

1 reference

25 December 2017

E Southam

7

1 reference

25 December 2017

publication date

3 December 2005

1 reference

25 December 2017

published in

Psychopharmacology

1 reference

25 December 2017

volume

184

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

page(s)

13-20

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1007/s00213-005-0222-1

exact match

0 references

cites work

Ziprasidone: a review of its use in schizophrenia and schizoaffective disorder

1 reference

12 December 2020

Antagonism by 8-OH-DPAT, but not ritanserin, of catalepsy induced by SCH 23390 in the rat

1 reference

12 December 2020

The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics?

1 reference

12 December 2020

M100907, a selective 5-HT(2A) receptor antagonist, attenuates phencyclidine-induced Fos expression in discrete regions of rat brain

1 reference

12 December 2020

Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile

1 reference

12 December 2020

Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine

1 reference

12 December 2020

Blockade of drug-induced deficits in prepulse inhibition of acoustic startle by ziprasidone

1 reference

12 December 2020

Increasing D2 affinity results in the loss of clozapine's atypical antipsychotic action

1 reference

12 December 2020

Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: The nucleus accumbens shell as a locus of antipsychotic action

1 reference

12 December 2020

Modification of haloperidol-induced pattern of c-fos expression by serotonin agonists.

1 reference

12 December 2020

Possible implications of the dopamine D(3) receptor in schizophrenia and in antipsychotic drug actions

1 reference

12 December 2020

Induction of c-fos mRNA in rat medial prefrontal cortex by antipsychotic drugs: role of dopamine D2 and D3 receptors

1 reference

12 December 2020

D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons

1 reference

12 December 2020

8-Hydroxy-2-(di-n-propylamino) tetralin, a selective serotonin1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis

1 reference

12 December 2020

Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study Group

1 reference

12 December 2020

Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity

1 reference

12 December 2020

Testing the validity of c-fos expression profiling to aid the therapeutic classification of psychoactive drugs.

1 reference

12 December 2020

Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity

1 reference

12 December 2020

Acute administration of typical and atypical antipsychotic drugs induces distinctive patterns of Fos expression in the rat forebrain

1 reference

12 December 2020

Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist

1 reference

12 December 2020

Effect of 5-HT1A receptor-mediated serotonin augmentation on Fos immunoreactivity in rat brain

1 reference

12 December 2020

Ziprasidone: comprehensive overview and clinical use of a novel antipsychotic

1 reference

12 December 2020

Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values

1 reference

12 December 2020

Limited participation of 5-HT(1A) and 5-HT(2A/2C) receptors in the clozapine-induced Fos-protein expression in rat forebrain regions

1 reference

12 December 2020

Double activity imaging reveals distinct cellular targets of haloperidol, clozapine and dopamine D(3) receptor selective RGH-1756.

1 reference

12 December 2020

10.1007/S00213-005-0222-1

Identifiers

DOI

1 reference

25 December 2017

release_sz4rrkdmgrh4lar64ln4ih6f6e

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sz4rrkdmgrh4lar64ln4ih6f6e

24 November 2022

mapped directly with Wikidata item

1 reference

25 December 2017